Levothyroxine 100mcg tablets - recall of Teva UK and Numark branded product

(Teva UK and Numark liveries) Remaining stock should be returned to wholesaler for credit – class 3 action within 5 days. (EL (12)A/13)

09 May 2012

Class 3 medicines recall

Action within 5 days

Pharmacy, wholesaler and clinic-level recall

MDR 7-12/11

Product details

Teva UK Limited

Levothyroxine 100mcg Tablets in Teva UK and Numark liveries

PL 00289/0039

Alert details

Teva UK Limited is recalling all remaining in-date stock of the above product. The marketing authorisation was suspended in February 2012 and the supply position was then too fragile to permit a recall. Adequate supplies of alternative Levothyroxine 100 mcg tablets are now available which  allows a recall of the remaining Teva UK and Numark branded product.

This recall is restricted to the 100mcg strength only of these presentations. No other strengths or brands are included in the scope of the recall.

Remaining stocks of these products should be returned to the original wholesaler for credit.  For further stock enquiries please contact Teva UK Customer Liaison Team on 0800 590502.

For medical information enquiries please contact Teva UK Limited by phone on 0207 540 7117 or by email at medinfo@tevauk.com.

Recipients of this Drug Alert should bring it to the attention of relevant contacts by copy of this letter. Primary care trusts are asked to forward this to relevant clinics, general practitioners and community pharmacists for information.

MHRA distribution

Further recipients by cascade:

regional contacts for NHS trusts and provider units
Chief pharmacists: England, Scotland, Wales, Northern Ireland
Prison Health Policy Unit (DH)
Chief pharmacists: Jersey, Guernsey, Alderney, Sark, Isle of Man, Gibraltar
Special hospitals
Healthcare Commission for distribution to Independent health care establishments
Primary care trusts (England)

Download documents

Published 17 December 2014